Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib

Niklas Landberg, Arta Dreimane, Marianne Rissler, Rolf Billström, Helena Ågerstam

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science